Immuntherapien zur Behandlung der chronischen Hepatitis-B-Virusinfektion – eine Übersicht unter besonderer Berücksichtigung von CAR-T-Zellen

More than 250 million people worldwide suffer from chronic infection with hepatitis B virus (CHB). Chronic infection is associated with an increased risk of developing liver fibrosis/cirrhosis and hepatocellular carcinoma. Approximately 0.8–1 million people die annually as a result of CHB. One diffi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivics, Zoltan, Amberger, Maximilian, Zahn, Tobias, Hildt, Eberhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Leitthema
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647999/
https://www.ncbi.nlm.nih.gov/pubmed/32995895
http://dx.doi.org/10.1007/s00103-020-03223-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647999/
https://www.ncbi.nlm.nih.gov/pubmed/32995895
http://dx.doi.org/10.1007/s00103-020-03223-7

Ejemplares similares